Burnham Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Burnham Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,000	Closed	-$221K	–	223
2016 Q1	$221K	Hold	7,000	–	–	0.07%	195
2015 Q4	$317K	Hold	7,000	–	–	0.09%	185
2015 Q3	$292K	Sell	7,000 -8,000	-53%	-$417K	0.08%	189
2015 Q2	$904K	Buy	+15,000	New	+$992K	0.21%	107

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Burnham Asset Management's ONCE Position: Q2 2016 in Review

Burnham Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2016, closing a stake of 7,000 shares — an estimated $221K sold.

Burnham Asset Management first reported a position in ONCE in Q2 2015 and held it in 4 quarters. The position peaked at $904K in Q2 2015. 115 funds tracked by Wall St. Rank hold ONCE as of Q2 2016.

Burnham Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Burnham Asset Management sold 7,000 Spark Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $221K.
Burnham Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 4 quarters.
Burnham Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $904K in Q2 2015.
115 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.